ABSTRACT
BACKGROUND AND OBJECTIVES: Drug-induced immune hemolytic anemia is a rare condition that occurs primarily because of drug-induced antibodies, either dependent or independent and positive direct antiglobulin test. Our aim was to evaluate the association of positive DAT with nonreactive eluate and DIHA. MATERIALS AND METHODS: From 2014-2018, we evaluated 159 patients who presented positive DAT with a nonreactive eluate. Laboratory and clinical analyses were performed including HIV, HBV and HCV testing. All patients were exposed to the following drugs: Dipyrone in 63.5 %, Furosemide in 28.9 %, Metoclopramide in 34.6 % and Ondansetron in 41.5 %. RESULTS: Results of DAT showed IgG in 125 (78.4 %) patients and C3d in 24 (15.1 %) with reactions varying from 1+ to 4+. HIV test was positive in 10 (16.1 %) patients, HBV was positive in 3 (4.7 %) and HCV was positive in, 1 (1.5 %). There was no clinical significance when the parameters of hemoglobin, hematocrit, reticulocytes and LDH were evaluated, only a slight increase in bilirubin, especially, in patients with positive DAT reacting 3+/4+ due to IgG and C3d sensitization. Clinical evaluations showed that all patients were asymptomatic. CONCLUSIONS: The association of drugs with positive DAT can be a challenge to transfusion services and immunohematology reference laboratories. There was no evidence of any case of severe hemolysis with clinical repercussion through the clinical and laboratory findings analyzed with the drugs associated with positive DAT. Dipyrone and Furosemide have already been associated with DIHA but there are no studies reporting the association of Metoclopramide and Ondansetron with DIHA.
Subject(s)
Anemia, Hemolytic/chemically induced , Coombs Test/methods , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Female , Humans , Male , Middle Aged , Young AdultABSTRACT
Method: An observational, retrospective, descriptive and cross - sectional study was carried out with data collected from Clínica Basegio, Brazil. The objective of this study was to analyze the importance of breast self-examination (BSE) as a diagnostic method for breast cancer in Passo Fundo, Rio Grande do Sul. A total of 320 patient records were selected from 1987 to 2017, among which 14 were excluded due to insufficient information. Results: BSE accounted for 48% of breast cancer diagnoses, followed by mammography and ultrasound. Imaging methods proved to be more effective in diagnosing early stage disease, while BSE detected more advanced tumors. This data was based on the histological characteristics of the tumors, with a significant difference (p<0.05) between tumor size and lymph node involvement when compared to BSE and imaging methods. Thus, the survival of the patients diagnosed by mammography and ultrasound was significantly higher than the patients diagnosed by BSE. Conclusion: Evidence from this retrospective study suggests that BSE is the prevalent diagnostic method for breast cancer in the State of Rio Grande do Sul. Despite detecting tumors in advanced stages, it is still a fundamental method within the Brazilian reality.
Método: Estudo observacional, retrospectivo, descritivo e transversal, com dados coletados na Clínica Basegio, Brasil. O objetivo deste estudo foi analisar a importância do autoexame das mamas (AEM) como método diagnóstico para o câncer de mama em Passo Fundo, Rio Grande do Sul. Um total de 320 registros de pacientes foram selecionados de 1987 a 2017, dos quais 14 foram excluídos devido a informações insuficientes. Resultados: O AEM foi responsável por 48% dos diagnósticos de câncer de mama, seguido pela mamografia e ultrassonografia. Os métodos de imagem mostraram-se mais eficazes no diagnóstico de doença em estágio inicial, enquanto o AEM detectou tumores mais avançados. Esses dados foram baseados nas características histológicas dos tumores, com diferença significativa (p<0,05) entre o tamanho do tumor e o comprometimento linfonodal quando comparados aos métodos de AEM e de imagem. Assim, a sobrevida dos pacientes diagnosticados por mamografia e ultrassonografia foi significativamente maior que a de pacientes diagnosticados por AEM. Conclusão: Evidências deste estudo retrospectivo sugerem que o AEM é o método diagnóstico prevalente para o câncer de mama no Estado do Rio Grande do Sul. Apesar de detectar tumores em estágios avançados, ainda é um método fundamental dentro da realidade brasileira.
